Sodium nitroprusside

🧮 Dose calculator

Hypertensive emergency (hospital) · Regimen source: FDA Nipride RTU · 2.2

• • Continuous BP monitoring; wait ≥5 min before changing. Volumetric pump only. Do not use blue, green or bright-red solution. At the maximum rate, cyanide buffering capacity is exceeded in under 1 h. FDA Nipride RTU · 2.2FDA Nipride RTU · 2.3FDA Nipride RTU · 2.1FDA Nipride RTU · Boxed Warning

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Nipride RTU · 8.1

  “Risk Summary Based on animal data and mechanism of action, sodium nitroprusside may lead to cyanide exposure and potential adverse effects in the fetus [see Clinical Pharmacology ( 12.3 ) and Clinical Considerations] .”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Nipride RTU · 8.2

  “Risk Summary There is no information about the presence of sodium nitroprusside in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Nipride RTU · 8.4

  “Efficacy in the pediatric population was established based on adult trials and supported by the dose-ranging trial (Study 1) and an open label trial of at least 12 hour infusion at a rate that achieved adequate MAP control (Study 2) with pediatric patients on sodium nitroprusside.”

• 👴 Older adultsNo data

  The source for this drug has no section for this group.

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.